ARPA-H’s clinical trial push reportedly aims to cut timelines from 10-plus years to under four

ARPA-H shared an “Advancing Clinical Trials” announcement. A commentator says its plan aims to cut trial times from 10-plus years to under four through adaptive “phaseless” trials, digital-twin simulations, AI agents for trial operations and reusable trial sites at ordinary hospitals. The commentator says the simulations could reduce reliance on large control groups, while AI could flag eligible trials to doctors and patients.